These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26010870)

  • 1. Interruption of Pacing Following Nonsustained Ventricular Tachycardia in an AAI Programmed Implantable Cardioverter Defibrillator.
    Egan P; Wilkoff BL; Tchou P
    Pacing Clin Electrophysiol; 2015 Sep; 38(9):1082-90. PubMed ID: 26010870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICD proarrhythmia as a consequence of an interaction with an algorithm to prevent atrial arrhythmias.
    Martínez-Sánchez J; García-Alberola A; Sánchez-Muñoz JJ; Peñafiel-Verdú P; Giner-Caro JA; Valdés-Chávarri M
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1096-8. PubMed ID: 19659632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia?
    Sweeney MO; Ruetz LL; Belk P; Mullen TJ; Johnson JW; Sheldon T
    J Am Coll Cardiol; 2007 Aug; 50(7):614-22. PubMed ID: 17692746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking preference as unusual trigger of pacemaker-mediated tachycardia in a resynchronization device.
    Crea P; Picciolo G; Luzza F
    J Electrocardiol; 2016; 49(4):509-11. PubMed ID: 26976512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular pacing induced ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Roelke M; O'Nunain S; Osswald S; Trouton TG; Harthorne JW; Garan H; Ruskin JN
    Pacing Clin Electrophysiol; 1995 Mar; 18(3 Pt 1):486-91. PubMed ID: 7770372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL;
    Europace; 2019 Sep; 21(9):1442-1443. PubMed ID: 31090914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
    Stiles MK; Fauchier L; Morillo CA; Wilkoff BL
    J Interv Card Electrophysiol; 2020 Oct; 59(1):135-144. PubMed ID: 31960345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intradevice interaction in a dual chamber implantable cardioverter defibrillator preventing ventricular tachyarrhythmia detection.
    Shivkumar K; Feliciano Z; Boyle NG; Wiener I
    J Cardiovasc Electrophysiol; 2000 Nov; 11(11):1285-8. PubMed ID: 11083251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.
    Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A
    J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The benefit of a second burst antitachycardia sequence for fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
    Anguera I; Dallaglio P; Sabaté X; Nuñez E; Gracida M; Di Marco A; Sugrañes G; Cequier A
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):486-94. PubMed ID: 24215374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
    Grimm W; Plachta E; Maisch B
    Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT.
    Mittal S; Aktas MK; Moss AJ; McNitt S; Kutyifa V; Steinberg JS; Zareba W
    J Cardiovasc Electrophysiol; 2014 Oct; 25(10):1082-7. PubMed ID: 24862906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial.
    Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M
    Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with an implantable tiered therapy device incorporating antitachycardia pacing and cardioverter/defibrillator therapy.
    Mitchell JD; Lee R; Garan H; Ruskin JN; Torchiana DF; Vlahakes GJ
    J Thorac Cardiovasc Surg; 1993 Mar; 105(3):453-62; discussion 462-3. PubMed ID: 8445925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
    Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
    Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Delayed detection of ventricular tachycardia due to intradevice interactions by implantable atrio-ventricular pacer/cardioverter defibrillator.
    Kantharia BK; Padder FA
    J Interv Card Electrophysiol; 2006 Aug; 16(2):135-8. PubMed ID: 17016683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.